The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Japanese Encephalitis Inactivated Vaccine Market Research Report 2025

Global Japanese Encephalitis Inactivated Vaccine Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1728275

No of Pages : 91

Ask Your Query

Synopsis
Highlights
The global Japanese Encephalitis Inactivated Vaccine market is projected to reach US$ million by 2028 from an estimated US$ million in 2022, at a CAGR of % during 2023 and 2028.
The major global manufacturers of Japanese Encephalitis Inactivated Vaccine include Valneva, Sanofi Pasteur, Biken, Lanzhou Institute of Biological Products Co., Ltd, Liaoning Chengda Biological Co., Ltd, Beijing Institute of Biological Products Co., Ltd and Chengdu Institute of Biological Products Co., Ltd, etc. In 2021, the world's top three vendors accounted for approximately % of the revenue.
Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, Adult, which accounted for % of the global market of Japanese Encephalitis Inactivated Vaccine in 2021, is expected to reach million US$ by 2028, growing at a revised CAGR of % from 2022 to 2028.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Japanese Encephalitis Inactivated Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Japanese Encephalitis Inactivated Vaccine.
The Japanese Encephalitis Inactivated Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Japanese Encephalitis Inactivated Vaccine market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Japanese Encephalitis Inactivated Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.

Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.

Some of the prominent players reviewed in the research report include:

  • Valneva
  • Sanofi Pasteur
  • Biken
  • Lanzhou Institute of Biological Products Co., Ltd
  • Liaoning Chengda Biological Co., Ltd
  • Beijing Institute of Biological Products Co., Ltd
  • Chengdu Institute of Biological Products Co., Ltd

Product Type Insights
Global markets are presented by Japanese Encephalitis Inactivated Vaccine type, along with growth forecasts through 2028. Estimates on sales and revenue are based on the price in the supply chain at which the Japanese Encephalitis Inactivated Vaccine are procured by the manufacturers.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and during the historical period (2017-2022) and forecast period (2023-2028).

Japanese Encephalitis Inactivated Vaccine segment by Type

  • Adult
  • Child

Application Insights
This report has provided the market size (sales and revenue data) by application, during the historical period (2017-2022) and forecast period (2023-2028).
This report also outlines the market trends of each segment and consumer behaviors impacting the Japanese Encephalitis Inactivated Vaccine market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Japanese Encephalitis Inactivated Vaccine market.

Japanese Encephalitis Inactivated Vaccine segment by Application

  • Hospital
  • Clinic

Regional Outlook
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2017-2028.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2022 and forecast revenue for 2028.

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil, Argentina, Colombia)

Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Japanese Encephalitis Inactivated Vaccine market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Reasons to Buy This Report

  • This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Japanese Encephalitis Inactivated Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
  • This report will help stakeholders to understand the global industry status and trends of Japanese Encephalitis Inactivated Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.
  • This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
  • This report stays updated with novel technology integration, features, and the latest developments in the market
  • This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Japanese Encephalitis Inactivated Vaccine industry.
  • This report helps stakeholders to gain insights into which regions to target globally
  • This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Japanese Encephalitis Inactivated Vaccine.
  • This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Japanese Encephalitis Inactivated Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Japanese Encephalitis Inactivated Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Analysis of sales channel, distributors and customers
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: sales and revenue forecast, global and regional, by Type and by Application. It provides a quantitative analysis of the market size and development potential of each market segment in the next six years.
Chapter 11: The main points and conclusions of the report.

Index

1 Japanese Encephalitis Inactivated Vaccine Market Overview
1.1 Product Overview and Scope of Japanese Encephalitis Inactivated Vaccine
1.2 Japanese Encephalitis Inactivated Vaccine Segment by Type
1.2.1 Global Japanese Encephalitis Inactivated Vaccine Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 Adult
1.2.3 Child
1.3 Japanese Encephalitis Inactivated Vaccine Segment by Application
1.3.1 Global Japanese Encephalitis Inactivated Vaccine Sales Comparison by Application: (2022-2028)
1.3.2 Hospital
1.3.3 Clinic
1.4 Global Japanese Encephalitis Inactivated Vaccine Market Size Estimates and Forecasts
1.4.1 Global Japanese Encephalitis Inactivated Vaccine Revenue 2017-2028
1.4.2 Global Japanese Encephalitis Inactivated Vaccine Sales 2017-2028
1.4.3 Japanese Encephalitis Inactivated Vaccine Market Size by Region: 2017 Versus 2021 Versus 2028
2 Japanese Encephalitis Inactivated Vaccine Market Competition by Manufacturers
2.1 Global Japanese Encephalitis Inactivated Vaccine Sales Market Share by Manufacturers (2017-2022)
2.2 Global Japanese Encephalitis Inactivated Vaccine Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Japanese Encephalitis Inactivated Vaccine Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Japanese Encephalitis Inactivated Vaccine Manufacturing Sites, Area Served, Product Type
2.5 Japanese Encephalitis Inactivated Vaccine Market Competitive Situation and Trends
2.5.1 Japanese Encephalitis Inactivated Vaccine Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Japanese Encephalitis Inactivated Vaccine Players Market Share by Revenue
2.5.3 Global Japanese Encephalitis Inactivated Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Japanese Encephalitis Inactivated Vaccine Retrospective Market Scenario by Region
3.1 Global Japanese Encephalitis Inactivated Vaccine Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Japanese Encephalitis Inactivated Vaccine Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Japanese Encephalitis Inactivated Vaccine Market Facts & Figures by Country
3.3.1 North America Japanese Encephalitis Inactivated Vaccine Sales by Country
3.3.2 North America Japanese Encephalitis Inactivated Vaccine Revenue by Country
3.3.3 United States
3.3.4 Canada
3.4 Europe Japanese Encephalitis Inactivated Vaccine Market Facts & Figures by Country
3.4.1 Europe Japanese Encephalitis Inactivated Vaccine Sales by Country
3.4.2 Europe Japanese Encephalitis Inactivated Vaccine Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Japanese Encephalitis Inactivated Vaccine Market Facts & Figures by Region
3.5.1 Asia Pacific Japanese Encephalitis Inactivated Vaccine Sales by Region
3.5.2 Asia Pacific Japanese Encephalitis Inactivated Vaccine Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Japanese Encephalitis Inactivated Vaccine Market Facts & Figures by Country
3.6.1 Latin America Japanese Encephalitis Inactivated Vaccine Sales by Country
3.6.2 Latin America Japanese Encephalitis Inactivated Vaccine Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.6.6 Colombia
3.7 Middle East and Africa Japanese Encephalitis Inactivated Vaccine Market Facts & Figures by Country
3.7.1 Middle East and Africa Japanese Encephalitis Inactivated Vaccine Sales by Country
3.7.2 Middle East and Africa Japanese Encephalitis Inactivated Vaccine Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Japanese Encephalitis Inactivated Vaccine Historic Market Analysis by Type
4.1 Global Japanese Encephalitis Inactivated Vaccine Sales Market Share by Type (2017-2022)
4.2 Global Japanese Encephalitis Inactivated Vaccine Revenue Market Share by Type (2017-2022)
4.3 Global Japanese Encephalitis Inactivated Vaccine Price by Type (2017-2022)
5 Global Japanese Encephalitis Inactivated Vaccine Historic Market Analysis by Application
5.1 Global Japanese Encephalitis Inactivated Vaccine Sales Market Share by Application (2017-2022)
5.2 Global Japanese Encephalitis Inactivated Vaccine Revenue Market Share by Application (2017-2022)
5.3 Global Japanese Encephalitis Inactivated Vaccine Price by Application (2017-2022)
6 Key Companies Profiled
6.1 Valneva
6.1.1 Valneva Corporation Information
6.1.2 Valneva Description and Business Overview
6.1.3 Valneva Japanese Encephalitis Inactivated Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.1.4 Valneva Japanese Encephalitis Inactivated Vaccine Product Portfolio
6.1.5 Valneva Recent Developments/Updates
6.2 Sanofi Pasteur
6.2.1 Sanofi Pasteur Corporation Information
6.2.2 Sanofi Pasteur Description and Business Overview
6.2.3 Sanofi Pasteur Japanese Encephalitis Inactivated Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.2.4 Sanofi Pasteur Japanese Encephalitis Inactivated Vaccine Product Portfolio
6.2.5 Sanofi Pasteur Recent Developments/Updates
6.3 Biken
6.3.1 Biken Corporation Information
6.3.2 Biken Description and Business Overview
6.3.3 Biken Japanese Encephalitis Inactivated Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.3.4 Biken Japanese Encephalitis Inactivated Vaccine Product Portfolio
6.3.5 Biken Recent Developments/Updates
6.4 Lanzhou Institute of Biological Products Co., Ltd
6.4.1 Lanzhou Institute of Biological Products Co., Ltd Corporation Information
6.4.2 Lanzhou Institute of Biological Products Co., Ltd Description and Business Overview
6.4.3 Lanzhou Institute of Biological Products Co., Ltd Japanese Encephalitis Inactivated Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Lanzhou Institute of Biological Products Co., Ltd Japanese Encephalitis Inactivated Vaccine Product Portfolio
6.4.5 Lanzhou Institute of Biological Products Co., Ltd Recent Developments/Updates
6.5 Liaoning Chengda Biological Co., Ltd
6.5.1 Liaoning Chengda Biological Co., Ltd Corporation Information
6.5.2 Liaoning Chengda Biological Co., Ltd Description and Business Overview
6.5.3 Liaoning Chengda Biological Co., Ltd Japanese Encephalitis Inactivated Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.5.4 Liaoning Chengda Biological Co., Ltd Japanese Encephalitis Inactivated Vaccine Product Portfolio
6.5.5 Liaoning Chengda Biological Co., Ltd Recent Developments/Updates
6.6 Beijing Institute of Biological Products Co., Ltd
6.6.1 Beijing Institute of Biological Products Co., Ltd Corporation Information
6.6.2 Beijing Institute of Biological Products Co., Ltd Description and Business Overview
6.6.3 Beijing Institute of Biological Products Co., Ltd Japanese Encephalitis Inactivated Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.6.4 Beijing Institute of Biological Products Co., Ltd Japanese Encephalitis Inactivated Vaccine Product Portfolio
6.6.5 Beijing Institute of Biological Products Co., Ltd Recent Developments/Updates
6.7 Chengdu Institute of Biological Products Co., Ltd
6.6.1 Chengdu Institute of Biological Products Co., Ltd Corporation Information
6.6.2 Chengdu Institute of Biological Products Co., Ltd Description and Business Overview
6.6.3 Chengdu Institute of Biological Products Co., Ltd Japanese Encephalitis Inactivated Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Chengdu Institute of Biological Products Co., Ltd Japanese Encephalitis Inactivated Vaccine Product Portfolio
6.7.5 Chengdu Institute of Biological Products Co., Ltd Recent Developments/Updates
7 Japanese Encephalitis Inactivated Vaccine Manufacturing Cost Analysis
7.1 Japanese Encephalitis Inactivated Vaccine Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Japanese Encephalitis Inactivated Vaccine
7.4 Japanese Encephalitis Inactivated Vaccine Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Japanese Encephalitis Inactivated Vaccine Distributors List
8.3 Japanese Encephalitis Inactivated Vaccine Customers
9 Japanese Encephalitis Inactivated Vaccine Market Dynamics
9.1 Japanese Encephalitis Inactivated Vaccine Industry Trends
9.2 Japanese Encephalitis Inactivated Vaccine Market Drivers
9.3 Japanese Encephalitis Inactivated Vaccine Market Challenges
9.4 Japanese Encephalitis Inactivated Vaccine Market Restraints
10 Global Market Forecast
10.1 Japanese Encephalitis Inactivated Vaccine Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Japanese Encephalitis Inactivated Vaccine by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Japanese Encephalitis Inactivated Vaccine by Type (2023-2028)
10.2 Japanese Encephalitis Inactivated Vaccine Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Japanese Encephalitis Inactivated Vaccine by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Japanese Encephalitis Inactivated Vaccine by Application (2023-2028)
10.3 Japanese Encephalitis Inactivated Vaccine Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Japanese Encephalitis Inactivated Vaccine by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Japanese Encephalitis Inactivated Vaccine by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Tables

List of Tables
Table 1. Global Japanese Encephalitis Inactivated Vaccine Sales Growth Rate Comparison by Type (2022-2028) & (K Units) & (US$ Million)
Table 2. Global Japanese Encephalitis Inactivated Vaccine Sales Growth Rate Comparison by Application (2022-2028) & (K Units) & (US$ Million)
Table 3. Global Japanese Encephalitis Inactivated Vaccine Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
Table 4. Global Japanese Encephalitis Inactivated Vaccine Market Competitive Situation by Manufacturers in 2021
Table 5. Global Japanese Encephalitis Inactivated Vaccine Sales (K Units) of Key Manufacturers (2017-2022)
Table 6. Global Japanese Encephalitis Inactivated Vaccine Sales Market Share by Manufacturers (2017-2022)
Table 7. Global Japanese Encephalitis Inactivated Vaccine Revenue (US$ Million) by Manufacturers (2017-2022)
Table 8. Global Japanese Encephalitis Inactivated Vaccine Revenue Share by Manufacturers (2017-2022)
Table 9. Global Market Japanese Encephalitis Inactivated Vaccine Average Price (US$/Unit) of Key Manufacturers (2017-2022)
Table 10. Manufacturers Japanese Encephalitis Inactivated Vaccine Manufacturing Sites and Area Served
Table 11. Manufacturers Japanese Encephalitis Inactivated Vaccine Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Japanese Encephalitis Inactivated Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Japanese Encephalitis Inactivated Vaccine as of 2021)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Japanese Encephalitis Inactivated Vaccine Sales by Region (2017-2022) & (K Units)
Table 16. Global Japanese Encephalitis Inactivated Vaccine Sales Market Share by Region (2017-2022)
Table 17. Global Japanese Encephalitis Inactivated Vaccine Revenue by Region (2017-2022) & (US$ Million)
Table 18. Global Japanese Encephalitis Inactivated Vaccine Revenue Market Share by Region (2017-2022)
Table 19. North America Japanese Encephalitis Inactivated Vaccine Sales by Country (2017-2022) & (K Units)
Table 20. North America Japanese Encephalitis Inactivated Vaccine Sales Market Share by Country (2017-2022)
Table 21. North America Japanese Encephalitis Inactivated Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 22. North America Japanese Encephalitis Inactivated Vaccine Revenue Market Share by Country (2017-2022)
Table 23. Europe Japanese Encephalitis Inactivated Vaccine Sales by Country (2017-2022) & (K Units)
Table 24. Europe Japanese Encephalitis Inactivated Vaccine Sales Market Share by Country (2017-2022)
Table 25. Europe Japanese Encephalitis Inactivated Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 26. Europe Japanese Encephalitis Inactivated Vaccine Revenue Market Share by Country (2017-2022)
Table 27. Asia Pacific Japanese Encephalitis Inactivated Vaccine Sales by Region (2017-2022) & (K Units)
Table 28. Asia Pacific Japanese Encephalitis Inactivated Vaccine Sales Market Share by Region (2017-2022)
Table 29. Asia Pacific Japanese Encephalitis Inactivated Vaccine Revenue by Region (2017-2022) & (US$ Million)
Table 30. Asia Pacific Japanese Encephalitis Inactivated Vaccine Revenue Market Share by Region (2017-2022)
Table 31. Latin America Japanese Encephalitis Inactivated Vaccine Sales by Country (2017-2022) & (K Units)
Table 32. Latin America Japanese Encephalitis Inactivated Vaccine Sales Market Share by Country (2017-2022)
Table 33. Latin America Japanese Encephalitis Inactivated Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 34. Latin America Japanese Encephalitis Inactivated Vaccine Revenue Market Share by Country (2017-2022)
Table 35. Middle East and Africa Japanese Encephalitis Inactivated Vaccine Sales by Country (2017-2022) & (K Units)
Table 36. Middle East and Africa Japanese Encephalitis Inactivated Vaccine Sales Market Share by Country (2017-2022)
Table 37. Middle East and Africa Japanese Encephalitis Inactivated Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 38. Middle East and Africa Japanese Encephalitis Inactivated Vaccine Revenue Market Share by Country (2017-2022)
Table 39. Global Japanese Encephalitis Inactivated Vaccine Sales by Type (2017-2022) & (K Units)
Table 40. Global Japanese Encephalitis Inactivated Vaccine Sales Market Share by Type (2017-2022)
Table 41. Global Japanese Encephalitis Inactivated Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 42. Global Japanese Encephalitis Inactivated Vaccine Revenue Share by Type (2017-2022)
Table 43. Global Japanese Encephalitis Inactivated Vaccine Price by Type (2017-2022) & (US$/Unit)
Table 44. Global Japanese Encephalitis Inactivated Vaccine Sales (K Units) by Application (2017-2022)
Table 45. Global Japanese Encephalitis Inactivated Vaccine Sales Market Share by Application (2017-2022)
Table 46. Global Japanese Encephalitis Inactivated Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global Japanese Encephalitis Inactivated Vaccine Revenue Share by Application (2017-2022)
Table 48. Global Japanese Encephalitis Inactivated Vaccine Price by Application (2017-2022) & (US$/Unit)
Table 49. Valneva Corporation Information
Table 50. Valneva Description and Business Overview
Table 51. Valneva Japanese Encephalitis Inactivated Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 52. Valneva Japanese Encephalitis Inactivated Vaccine Product
Table 53. Valneva Recent Developments/Updates
Table 54. Sanofi Pasteur Corporation Information
Table 55. Sanofi Pasteur Description and Business Overview
Table 56. Sanofi Pasteur Japanese Encephalitis Inactivated Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 57. Sanofi Pasteur Japanese Encephalitis Inactivated Vaccine Product
Table 58. Sanofi Pasteur Recent Developments/Updates
Table 59. Biken Corporation Information
Table 60. Biken Description and Business Overview
Table 61. Biken Japanese Encephalitis Inactivated Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 62. Biken Japanese Encephalitis Inactivated Vaccine Product
Table 63. Biken Recent Developments/Updates
Table 64. Lanzhou Institute of Biological Products Co., Ltd Corporation Information
Table 65. Lanzhou Institute of Biological Products Co., Ltd Description and Business Overview
Table 66. Lanzhou Institute of Biological Products Co., Ltd Japanese Encephalitis Inactivated Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 67. Lanzhou Institute of Biological Products Co., Ltd Japanese Encephalitis Inactivated Vaccine Product
Table 68. Lanzhou Institute of Biological Products Co., Ltd Recent Developments/Updates
Table 69. Liaoning Chengda Biological Co., Ltd Corporation Information
Table 70. Liaoning Chengda Biological Co., Ltd Description and Business Overview
Table 71. Liaoning Chengda Biological Co., Ltd Japanese Encephalitis Inactivated Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 72. Liaoning Chengda Biological Co., Ltd Japanese Encephalitis Inactivated Vaccine Product
Table 73. Liaoning Chengda Biological Co., Ltd Recent Developments/Updates
Table 74. Beijing Institute of Biological Products Co., Ltd Corporation Information
Table 75. Beijing Institute of Biological Products Co., Ltd Description and Business Overview
Table 76. Beijing Institute of Biological Products Co., Ltd Japanese Encephalitis Inactivated Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 77. Beijing Institute of Biological Products Co., Ltd Japanese Encephalitis Inactivated Vaccine Product
Table 78. Beijing Institute of Biological Products Co., Ltd Recent Developments/Updates
Table 79. Chengdu Institute of Biological Products Co., Ltd Corporation Information
Table 80. Chengdu Institute of Biological Products Co., Ltd Description and Business Overview
Table 81. Chengdu Institute of Biological Products Co., Ltd Japanese Encephalitis Inactivated Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 82. Chengdu Institute of Biological Products Co., Ltd Japanese Encephalitis Inactivated Vaccine Product
Table 83. Chengdu Institute of Biological Products Co., Ltd Recent Developments/Updates
Table 84. Production Base and Market Concentration Rate of Raw Material
Table 85. Key Suppliers of Raw Materials
Table 86. Japanese Encephalitis Inactivated Vaccine Distributors List
Table 87. Japanese Encephalitis Inactivated Vaccine Customers List
Table 88. Japanese Encephalitis Inactivated Vaccine Market Trends
Table 89. Japanese Encephalitis Inactivated Vaccine Market Drivers
Table 90. Japanese Encephalitis Inactivated Vaccine Market Challenges
Table 91. Japanese Encephalitis Inactivated Vaccine Market Restraints
Table 92. Global Japanese Encephalitis Inactivated Vaccine Sales Forecast by Type (2023-2028) & (K Units)
Table 93. Global Japanese Encephalitis Inactivated Vaccine Sales Market Share Forecast by Type (2023-2028)
Table 94. Global Japanese Encephalitis Inactivated Vaccine Revenue Forecast by Type (2023-2028) & (US$ Million)
Table 95. Global Japanese Encephalitis Inactivated Vaccine Revenue Market Share Forecast by Type (2023-2028)
Table 96. Global Japanese Encephalitis Inactivated Vaccine Sales Forecast by Application (2023-2028) & (K Units)
Table 97. Global Japanese Encephalitis Inactivated Vaccine Sales Market Share Forecast by Application (2023-2028)
Table 98. Global Japanese Encephalitis Inactivated Vaccine Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 99. Global Japanese Encephalitis Inactivated Vaccine Revenue Market Share Forecast by Application (2023-2028)
Table 100. Global Japanese Encephalitis Inactivated Vaccine Sales Forecast by Region (2023-2028) & (K Units)
Table 101. Global Japanese Encephalitis Inactivated Vaccine Sales Market Share Forecast by Region (2023-2028)
Table 102. Global Japanese Encephalitis Inactivated Vaccine Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 103. Global Japanese Encephalitis Inactivated Vaccine Revenue Market Share Forecast by Region (2023-2028)
Table 104. Research Programs/Design for This Report
Table 105. Key Data Information from Secondary Sources
Table 106. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Japanese Encephalitis Inactivated Vaccine
Figure 2. Global Japanese Encephalitis Inactivated Vaccine Market Share by Type in 2021 & 2028
Figure 3. Adult Product Picture
Figure 4. Child Product Picture
Figure 5. Global Japanese Encephalitis Inactivated Vaccine Market Share by Application in 2021 & 2028
Figure 6. Hospital
Figure 7. Clinic
Figure 8. Global Japanese Encephalitis Inactivated Vaccine Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 9. Global Japanese Encephalitis Inactivated Vaccine Market Size (2017-2028) & (US$ Million)
Figure 10. Global Japanese Encephalitis Inactivated Vaccine Sales (2017-2028) & (K Units)
Figure 11. Japanese Encephalitis Inactivated Vaccine Sales Share by Manufacturers in 2021
Figure 12. Global Japanese Encephalitis Inactivated Vaccine Revenue Share by Manufacturers in 2021
Figure 13. The Global 5 and 10 Largest Japanese Encephalitis Inactivated Vaccine Players: Market Share by Revenue in 2021
Figure 14. Japanese Encephalitis Inactivated Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 15. Global Japanese Encephalitis Inactivated Vaccine Sales Market Share by Region (2017-2022)
Figure 16. Global Japanese Encephalitis Inactivated Vaccine Sales Market Share by Region in 2021
Figure 17. Global Japanese Encephalitis Inactivated Vaccine Revenue Market Share by Region (2017-2022)
Figure 18. Global Japanese Encephalitis Inactivated Vaccine Revenue Market Share by Region in 2021
Figure 19. United States Japanese Encephalitis Inactivated Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 20. Canada Japanese Encephalitis Inactivated Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 21. Germany Japanese Encephalitis Inactivated Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 22. France Japanese Encephalitis Inactivated Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 23. U.K. Japanese Encephalitis Inactivated Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 24. Italy Japanese Encephalitis Inactivated Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 25. Russia Japanese Encephalitis Inactivated Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 26. China Japanese Encephalitis Inactivated Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 27. Japan Japanese Encephalitis Inactivated Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 28. South Korea Japanese Encephalitis Inactivated Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 29. India Japanese Encephalitis Inactivated Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 30. Australia Japanese Encephalitis Inactivated Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 31. China Taiwan Japanese Encephalitis Inactivated Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 32. Indonesia Japanese Encephalitis Inactivated Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 33. Thailand Japanese Encephalitis Inactivated Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 34. Malaysia Japanese Encephalitis Inactivated Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 35. Mexico Japanese Encephalitis Inactivated Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 36. Brazil Japanese Encephalitis Inactivated Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 37. Argentina Japanese Encephalitis Inactivated Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 38. Colombia Japanese Encephalitis Inactivated Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 39. Turkey Japanese Encephalitis Inactivated Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 40. Saudi Arabia Japanese Encephalitis Inactivated Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 41. UAE Japanese Encephalitis Inactivated Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 42. Sales Market Share of Japanese Encephalitis Inactivated Vaccine by Type (2017-2022)
Figure 43. Manufacturing Cost Structure of Japanese Encephalitis Inactivated Vaccine
Figure 44. Manufacturing Process Analysis of Japanese Encephalitis Inactivated Vaccine
Figure 45. Japanese Encephalitis Inactivated Vaccine Industrial Chain Analysis
Figure 46. Channels of Distribution
Figure 47. Distributors Profiles
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock